Summary. Three cases of cerebellar hemangioblastoma were studied using the immunoperoxidase technique to localize 7-enolase, also known as neuronspecific enolase. The stromal cells demonstrated positive staining for 7-enolase, while endothelial cells and pericytes showed no reactivity. Two vascular lesions, an angiosarcoma and a cutaneous angioma, were studied and found to be nonreactive for 7-enolase. All tumors were also tested for factor VIII/von Willebrand factor, glial fibrillary acidic protein, and the S-100 protein. The lack of expression of 7-enolase in endothelial cells of hemangioblastomas demonstrates a clear antigenic distinction from neighboring 7-enolase-positive stromal cells. The significance of this finding and its implications for stromal cell histogenesis are discussed.
The cerebellar hemangioblastoma is a benign vascular neoplasm found alone or as part of the von HippelLindau disease complex [15, 16, 28, 30] . Light microscope and ultrastructural studies of this tumor have established the presence of two characteristic cell types: endothelial cells and stromal cells. Pericytes have also been found [4-6, 11, 20, 35] . The lipidcontaining stromal cells are unlike other normal or pathological cell types and their histogenesis remains unresolved [5, 26, 29, 30] .
Ultrastructural and tissue culture studies have generally supported the hypothesis that stromal cells Offprint requests to: J. A. Feldenzer (address see above) originate from angiogenic mesenchyme or tumor endothelial cells. Several factors do not support this concept. Transitional cells have not been demonstrated ultrastructurally, and Spence and Rubinstein were unable to show interconvertibility between endothelial and stromal cells in tissue culture [35] . Alternatively, it has been suggested that stromal cells are derived from tumor endothelial cells [2] or from fibrous astrocytes that progressively accumulate lipid [14] .
Immunohistochemical studies using glial fibrillary acidic protein (GFAP) and factor VIII/von Willebrand factor (FVIII/vWF) have added to the controversy. Kepes et al. conclude that the presence of GFAP in some stromal cells suggests that they are "lipidized astrocytes" [21] . Deck and Rubinstein contend that the presence of GFAP in a cell does not define a glial cell and that stromal cells are capable of taking up extracellular GFAP from neighboring reactive astrocytes [8] . Jurco et al. reported that FVIII/vWF, a specific endothelial cell marker, stained stromal cells positively in all sixteen hemangioblastomas studied [18] . However, McComb et al. detected no positive staining of stromal cells and emphasized the antigenic distinction of stromal and endothelial cells [25] .
Enolases are a group of glycolytic enzymes in which three immunologically distinct subunits, e, /~, and 7, have been characterized. The 7 subunit has been detected in high concentrations in both central and peripheral nervous tissue as eT-and 77-enolases [32] . The 77-enolase is homologous to the nervous systemspecific protein previously known as 14-3-2 [3] . Initial histochemical studies demonstrated the presence of 7-enolase in neurons and neuroendocrine (APUD system) cells [1, 19, 33] . It has also been detected in other tissues [10, 19] .
In this study, the expression of 7-enolase was examined in three cases ofcerebellar hemangioblastoma and two lesions known to arise from angiogenic precursors: an angiosarcoma and a cutaneous angioma. 
Materials and methods
Tissue was prepared from paraffin-embedded blocks and standard hematoxylin-eosin (H&E) staining was performed. Immunostaining was done using the avidin-biotin system [12] . Sections were deparaffinized, treated with 10% H202 in methanol followed by a phosphate-buffered saline (PBS) wash and then treated with normal goat serum. Antisera (Dako, Santa Barbara, CA, USA) against 7-enolase, GFAP, FVIII/vWF and S-100 protein and tissue were incubated and washed in PBS. Biotinlabeled goat anti-rabbit immunoglobulin was incubated with tissue, washed in PBS and then incubated with avidin-biotin peroxidase complex (Vector, Burlingame, CA, USA). Tissues were then washed and sections developed in diaminobenzidine: H202 (Sigma, St. Louis, MO, USA). Tissues were counterstained with hematoxylin [23] . In one case (case 3, see Table 1 ), tumor tissue was minced into 1-2mm a fragments and fixed in formaldehyde (3 %)-glutaraldehyde (3 %) with 0.1 M cacodylate buffer. Sections were postfixed, dehydrated and then embedded in Epon. Uranyl acetate (2%) was used for en bloc staining. Tissue was sectioned on a Sorval ultramicrotome (MT-2), stained with Raynaud's lead citrate and examined on a Zeiss 109 electron microscope.
Results
Clinical and pathological data are summarized in Table 1 . Operative findings revealed cystic cerebellar tumors with associated mural nodules in each case. H&E-stained sections demonstrated large stromal cells containing foamy cytoplasm separated by the endothelial cells of multiple thin-walled vessels. The stromal cells of all three hemangioblastomas were positive for ~-enolase (NSE) while endothelial cells were nonreactive (Figs. 1, 2) . The y-enolase reactivity was independent of the relative predominance of the endothelial (reticular variant) versus stromal cell (cellular variant) components of each hemangioblastoma. FVIII/vWF stained the endothelial cells but stromal cell reactivity was not observed (Fig. 3) . GFAP-positive cells, detected in each hemangioblastoma, were infrequent and mainly localized to the periphery of the tumor. The S-100 protein was detected in a few cells of each hemangioblastoma, although uniform staining could not be demonstrated. An ultrastructural study of one case revealed the two major cell types, but Weibel-Palade bodies could not be identified in either endothelial or stromal cells.
Two vascular tumors were studied with H&E and immunohistochemical methods. A cutaneous angioma demonstrated reactivity to FVIII/vWF but was nonreactive for 7-enolase, GFAP and S-100 protein.
Similarly, the malignant cells of an angiosarcoma showed no staining with 7-enolase, GFAP or S-100 protein while FVIII/vWF staining was positive.
Discussion
Stromal cell histogenesis has been debated since the original descriptions of the tumor by Lindau in 1926 and Cushing and Bailey in 1928 [7, 22] . Immunohistochemical studies have not established a mesodermal or neuroectodermal origin. GFAP-positive stromal cells have been suggested to arise from the uptake of extracellular lipid by "trapped astrocytes" [14, 21] . This suggestion is consistent with a fraction of stromal cells positive for S-100 [36] , since astrocytes contain S-100 protein. Others have proposed that stromal cells acquire extracellular GFAP from nearby "reactive astrocytes" [8] .
The use of FVIII/vWF [13, 24] has not clarified the issue. The data of Jurco et al. [18] are in direct [25] . These results and those of Jellinger and Denk on blood group isoantigens [17] indicate a clear antigenic distinction between stromal and endothelial cells. Ho's ultrastructural data on the presence of Weibel-Palade bodies in both stromal and endothelial cells support an angiogenic mescnchymal origin for stromal cells [11] . Ho suggests that FVIII/vWF staining of stromal cells is related to the presence of Weibel-Palade bodies which have been shown to contain von Willebrand protein [38] . He indicates that the lack of expression of FVIII/vWF in stromal cells demonstrated by McComb et al. was due to an insufficient number of Weibel-Palade bodies or their structural alteration with subsequent antigenic loss. The stromal cells in each case expressed 7-enolase, while endothelial tumor cells were nonreactive. 7-Enolase staining of these two cell types has not been previously reported in hemangioblastomas and offers further evidence of their antigenic distinction. In addition, an angiosarcoma and a cutaneous angioma, both known to arise from angiogenic precursors, were nonreactive for 7-enolase.
7-Enolase (NSE) is present in high concentrations in the central and peripheral nervous systems and J.A. Feldenzer and P. E. McKeever: y-Enolase in cerebellar hemangioblastomas in neuroendocrine cells (APUD system) [1, 19, 33] . Reactive astrocytes and several central nervous system tumors focally stain positive for 7-enolase [9, 37] . Schmechel et al. have shown that neurons switch from non-neuronal enolase (~) to neuron-specific enolase (77) in developing rat and rhesus monkey brains [34] . This switch is closely correlated to the differentiated state and occurs in neurons of cerebellum and neocortex. The presence of 7-enolase in stromal cells may reflect a derivation from neuronal, astrocytic or neuroendocrine precursors. However, the "presence" of immunoreactive 7-enolase as a specific marker has been questioned [27, 31] . It has been suggested that quantitative measurement in addition to localization will provide the most useful information regarding its significance [31] .
Kato et al. detected 7-enolase in other human organ systems using a sensitive enzyme immunoassay method [19] . Haimoto et al. localized 7-enolase in a variety of human tissues [10] . Although 7-enolase was demonstrated in the smooth muscle cells of the media of the aorta and of the afferent arteries of the juxtaglomerular apparatus, vascular endothelial cells were nonreactive. Recently, Pahlman et al. detected 7-enolase in neuroendocrine and nonneuroendocrine tumor specimens and derived cell lines by enzymatic methods and radioimmunoassay [27] . They conclude that 7-enolase is not exclusively expressed in neuroendocrine tumor cells. The variety of sites in which 7-enolase has been found underscores the significant absence of 7-enolase in endothelial cells contrasted with its presence in stromal cells. Thus, 7-enolase provides additional new evidence of the difference between these cellular populations.
However, because 7-enolase expression is not specifically restricted to neurons or neuroendocrine cells., but is also found in normal tissues and nonneuroendocrine tumor cells, its significance regarding stromal cell histogenesis must be questioned. The presence or absence of 7-enolase may simply reflect the present metabolic needs of the cell type without relation to its line derivation. Nevertheless, this study has clearly demonstrated another antigenic distinction between stromal and endothelial cells of hemangioblastomas. Any hypothesis suggesting stromal cell derivation from endothelial tumor cells should account for this fact.
